Health
Human recombinant soluble ACE2 successfully used in a patient with severe COVID-19 – News-Medical.Net
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
A multinational research group recently published a paper in the journal Lancet Respiratory Medicine which describes the first patient with a severe form of coronavirus disease (COVID-19) that was successfully treated with human recombinant soluble ACE2.
A pandemic spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for almost one million deaths due to COVID-19. Therefore, important insights into the viral pathophysiology may facilitate the quest for an eff…
-
Noosa News22 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General24 hours agoKen Hinkley has called time at the Power, but he’s the ‘proudest coach the world has seen’
-
General18 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
General14 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals